102771-00-6

Basic information

• Product Name: 2-Iodo-5-(trifluoroMethyl)phenol
• Synonyms: 2-Iodo-5-(trifluoroMethyl)phenol;PHENOL,2-IODO-5-(TRIFLUOROMETHYL)-
• CAS NO: 102771-00-6
• Molecular Formula: C₇H₄F₃IO
• Molecular Weight: 288.0057396
• Mol File: 102771-00-6.mol

Chemical Properties

• Boiling Point: 201.3°C at 760 mmHg
• Flash Point: 75.5°C
• Appearance: /
• Density: 2.007g/cm³
• Vapor Pressure: 0.219mmHg at 25°C
• Refractive Index: 1.554
• PKA: 7.51±0.10(Predicted)
• CAS DataBase Reference: 2-Iodo-5-(trifluoroMethyl)phenol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Iodo-5-(trifluoroMethyl)phenol(102771-00-6)
• EPA Substance Registry System: 2-Iodo-5-(trifluoroMethyl)phenol(102771-00-6)

Safety Data

• Hazardous Substances Data: 102771-00-6(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
2-Iodo-5-(trifluoroMethyl)phenol is used as a reagent in organic synthesis for its unique chemical properties. The presence of the iodo and trifluoromethyl groups allows it to participate in a variety of chemical reactions, making it a versatile building block for the creation of new compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-Iodo-5-(trifluoroMethyl)phenol is used as a building block for the synthesis of various biologically active compounds. Its unique structure and reactivity contribute to the development of new drugs with potential therapeutic applications.
Used in Controlled Environments:
Due to its potentially hazardous nature, 2-Iodo-5-(trifluoroMethyl)phenol should be handled with caution and used in a controlled environment with proper safety measures in place. This ensures the safety of those working with the compound and minimizes the risk of accidents or exposure to harmful effects.

InChI:InChI=1/C7H4F3IO/c8-7(9,10)4-1-2-5(11)6(12)3-4/h1-3,12H

Upstream product

• 98-17-9 3-Trifluoromethylphenol 
• 334018-79-0 1-(trifluoromethyl)-3-(methoxymethoxy)benzene 
• 956219-18-4 C₁₁H₁₂F₃NO₂ 

Downstream Products

• 336625-15-1 ethyl (2-iodo-5-trifluoromethyl-phenoxy)acetate 
• 1449696-93-8 6,6′-(ethyne-1,2-diyl)bis[3-(trifluoromethyl)phenol] 
• 1449697-00-0 1,2-bis[2-(methoxymethoxy)-4-(trifluoromethyl)phenyl]ethyne 
• 1261752-45-7 1-iodo-2-methoxy-4-(trifluoromethyl)benzene 
• 1379680-40-6 C₃₈H₂₆F₆P₂ 
• 1379680-39-3 C₃₈H₂₆F₆O₂P₂ 
• 337529-30-3 [1R-[1α(Z),2β(1E),3α,5α]]-7-[5-hydroxy-2-[[4-(2-iodo-5-trifluoromethyl)phenoxy]-3-[(tetrahydro-2H-pyran-2-yl)oxy]-1-butenyl]-3-[(tetrahydro-2H-pyran-2-yl)oxy]cyclopentyl]-5-heptenoic acid 1-methylethyl ester 

Relevant articles and documents

Visible-Light-Induced Radical Carbo-Cyclization/ gem-Diborylation through Triplet Energy Transfer between a Gold Catalyst and Aryl Iodides

Geminal diboronates have attracted significant attention because of their unique structures and reactivity. However, benzofuran-, indole-, and benzothiophene-based benzylic gem-diboronates, building blocks for biologically relevant compounds, are unknown. A promising protocol using visible light and aryl iodides for constructing valuable building blocks, including benzofuran-, indole-, and benzothiophene-based benzylic gem-diboronates, via radical carbo-cyclization/gem-diborylation of alkynes with a high functional group tolerance is presented. The utility of these gem-diboronates has been demonstrated by a 10 g scale conversion, by versatile transformations, by including the synthesis of approved drug scaffolds and two approved drugs, and even by polymer synthesis. The mechanistic investigation indicates that the merging of the dinuclear gold catalyst (photoexcitation by 315-400 nm UVA light) with Na2CO3 is directly responsible for photosensitization of aryl iodides (photoexcitation by 254 nm UV light) with blue LED light (410-490 nm, λmax = 465 nm) through an energy transfer (EnT) process, followed by homolytic cleavage of the C-I bond in the aryl iodide substrates.

N-(PYRIDIN-2-YLSULFONYL)CYCLOPROPANECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF A CFTR MEDIATED DISEASE

The invention relates to heterocyclic compounds of the formula (I), in which all of the variables are as defined in the specification; capable of modulating the activity of CFTR. The invention further provides a method for manufacturing compounds of the invention, and its therapeutic uses. The invention further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including Cystic fibrosis and related disorders.

NEW COMPOUND HAVING FGFR INHIBITORY ACTIVITY AND PREPARATION AND APPLICATION THEREOF

The present invention relates to a new compound having an FGFR inhibitory activity and preparation and application thereof. In particular, the compound according to the present invention has a structure as shown in formula I, wherein each group and substituent are as defined in the description. Also disclosed in the present invention are a preparation method for the compound and a use thereof in preparation of a drug for treating and/or preventing a tumor-related disease and/or an FGFR-related disease.

Method for synthesizing asymmetric C-O coupled compound and application of asymmetric C-O coupled compound

The invention discloses a method for synthesizing an asymmetric C-O coupled compound and application of the asymmetric C-O coupled compound and belongs to the technical field of chemical synthesis. According to the method, a compound represented by a form

Exploring the potential of diarylacetylenediols as hydrogen bonding catalysts

In the course of a search for new classes of hydrogen bonding catalysts, we have examined diarylacetylenediols as potential catalysts for the Diels-Alder reaction. General and efficient methods have been developed for the preparation of these diols. Their structures were systematically modified, and increased activity was observed for those possessing an electron-withdrawing group on the aryl groups. The electron-deficient diarylacetylenediol catalysts, while more active, undergo spontaneous cyclization to the corresponding benzo[b]furans. A mechanism is postulated to explain this facile transformation. Computational studies performed on 2-ethynylphenol help to explain the effect of the alkyne on the conformation and hydrogen bond donating ability of the adjacent OH group. Finally, the crystal structure of one of the diols is reported, and it displays an intricate network of intermolecular hydrogen bonds.

Stable axial chirality in metal complexes bearing 4,4′-substituted BIPHEPs: Application to catalytic asymmetric carbon-carbon bond-forming reactions

Not only electronic but also steric effects of 4,4′-substituents in BIPHEP derivatives and metal (Pd, Pt, and Au) complexes are shown to influence the stability of the biphenyl single bond rotation. While electron-donating or sterically demanding substituents on the 4,4′-positions destabilize the axial chirality of BIPHEP derivatives, electron-withdrawing or sterically less demanding ones on the 4,4′-positions stabilize the axis chirality. Particularly, the axial chirality of palladium dichloride complexes bearing BIPHEP with t-Bu and CF3 substituents on the 4,4′-positions is most labile and stable, respectively (ΔG≠ = 29.22 and 30.49 kcal mol-1 at 300 K; t1/2 = 7 and 56 years at 300 K). These enantiopure dicationic BIPHEPPd complexes can be employed for catalytic enantioselective arylation, alkenylation, and ene reactions to give the corresponding products in good-to-excellent yields and enantioselectivities. Significantly, in the carbonyl-ene reaction of trifluoropyruvate with isobutene, the turnover frequency (TOF) reached 58200 h-1. The remarkable effects of 4,4′-substituents in BIPHEP derivatives can be employed as a guiding principle in the design of versatile and efficient ligands.

HETEROCYCLIDENE-N-(ARYL)ACETAMIDE DERIVATIVE

The blow-described formula (I): [Ch. 1] a compound represented by formula (I) : (wherein k, m, n, and p each represent 0 to 2; j and q represents 0 or 1; R1 represents a halogen atom, a hydrocarbon group, a heterocyclic group, an alkoxy group,

Novel Heterocyclidene Acetamide Derivative

A compound represented by formula (I′): (wherein m, n, and p each represent 0 to 2; q represents 0 or 1; R1 represents halogen, a hydrocarbon group, a heterocyclic group, an alkoxy group, an alkoxycarbonyl group, a sulfamoyl group, a CN group,

NOVEL HETEROCYCLIDENE ACETAMIDE DERIVATIVE

A compound represented by formula (I'): (wherein m, n, and p each represent 0 to 2; q represents 0 or 1; R1 represents halogen, a hydrocarbon group, a heterocyclic group, an alkoxy group, an alkoxycarbonyl group, a sulfamoyl group, a CN group,

Facile preparation of 2-iodophenyl trifluoromethanesulfonates: Superior aryne precursors

A comparative study of 3-methoxyaryne precursors revealed 2-iodo-3-methoxyphenyl triflate as the most effective in nonpolar solvent. Use of Hoppe's N-isopropyl carbamate allows for the systematic preparation of a variety of 2-iodophenyl triflates via a directed ortho-lithiation-iodination- decarbamation sequence. These steps are possible without isolation of the intermediate iodophenyl carbamates. Georg Thieme Verlag Stuttgart.